Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA:: evidence supporting the DNA pol γ hypothesis

被引:91
作者
Lewis, W
Kohler, JJ
Hosseini, SH
Haase, CP
Copeland, WC
Bienstock, RJ
Ludaway, T
McNaught, J
Russ, R
Stuart, T
Santoianni, R
机构
[1] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
[2] NIEHS, NIH, Res Triangle Pk, NC 27709 USA
关键词
mitochondria; deoxynucleotide carrier; nucleoside reverse transcriptase inhibitor; DNA polymerase; AIDS; transgenic; cardiomyopathy; heart;
D O I
10.1097/01.aids.0000216367.23325.58
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Design: Nucleoside reverse transcriptase inhibitors (NRTIs) exhibit mitochondrial toxicity. The mitochondrial deoxynucleotide carrier (DNC) transports nucleotide precursors (or phosphorylated NRTIs) into mitochondria for mitochondrial (mt)DNA replication or inhibition of mtDNA replication by NRTIs. Transgenic mice (TG) expressing human DNC targeted to murine myocardium served to define mitochondrial events from NRTIs in vivo and findings were corroborated by biochemical events in vitro. Methods: Zidovudine (3-azido-2',3'-deoxythymidine; ZDV), stavudine (2', 3'-didehydro-2', 3'-deoxythymidine; d4T), or lamivudine ((-)-2-deoxy-3'-thiacytidine; 3TC) were administered individually to TGs and wild-type (WT) littermates (35 days) at human doses with drug-free vehicle as control. Left ventricle (LV) mass was defined echocardiographically, mitochondrial ultrastructural defects were identified by electron microscopy, the abundance of cardiac mtDNA was quantified by real time polymerase chain reaction, and mtDNA-encoded polypeptides were quantified. Results: Untreated TGs exhibited normal LV mass with minor mitochondrial damage. NRTI monotherapy (either d4T or ZDV) increased LV mass in TGs and caused significant mitochondrial destruction. Cardiac mtDNA was depleted in ZDV and d4T-treated TG hearts and mtDNA-encoded polypeptides decreased. Changes were absent in 3TC-treated cohorts. In supportive structural observations from molecular modeling, ZDV demonstrated close contacts with K947 and Y951 in the DNA pol gamma active site that were absent in the HIV reverse transcriptase active site. Conclusions: NRTIs deplete mtDNA and polypeptides, cause mitochondrial structural and functional defects in vivo, follow inhibition kinetics with DNA pol gamma in vitro, and are corroborated by molecular models. Disrupted pools of nucleotide precursors and inhibition of DNA pol gamma by specific NRTIs are mechanistically important in mitochondrial toxicity. (C) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:675 / 684
页数:10
相关论文
共 55 条
[1]   DEPLETION OF MUSCLE MITOCHONDRIAL-DNA IN AIDS PATIENTS WITH ZIDOVUDINE-INDUCED MYOPATHY [J].
ARNAUDO, E ;
DALAKAS, M ;
SHANSKE, S ;
MORAES, CT ;
DIMAURO, S ;
SCHON, EA .
LANCET, 1991, 337 (8740) :508-510
[2]   Molecular insights into NRTI inhibition and mitochondrial toxicity revealed from a structural model of the human mitochondrial DNA polymerase [J].
Bienstock, RJ ;
Copeland, WC .
MITOCHONDRION, 2004, 4 (2-3) :203-213
[3]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[4]   Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway [J].
Brinkman, K ;
ter Hofstede, HJM ;
Burger, DM ;
Smeitinkt, JAM ;
Koopmans, PP .
AIDS, 1998, 12 (14) :1735-1744
[5]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099
[6]   Mutation Analysis in 16 Patients With mtDNA Depletion [J].
Carrozzo, R. ;
Bornstein, B. ;
Lucioli, S. ;
Campos, Y. ;
de la Pena, P. ;
Petit, N. ;
Dionisi-Vici, C. ;
Vilarinho, L. ;
Rizza, T. ;
Bertini, E. ;
Garesse, R. ;
Santorelli, F. M. ;
Arenas, J. .
HUMAN MUTATION, 2003, 21 (04) :453-454
[7]   Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy [J].
Cossarizza, A ;
Pinti, M ;
Moretti, L ;
Bricalli, D ;
Bianchi, R ;
Troiano, L ;
Fernandez, MG ;
Balli, F ;
Brambilla, P ;
Mussini, C ;
Viganò, A .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (03) :299-305
[8]   Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs:: actors or bystanders? [J].
Cossarizza, A ;
Mussini, C ;
Viganò, A .
BIOESSAYS, 2001, 23 (11) :1070-1080
[9]   Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens [J].
Côté, HCF ;
Yip, B ;
Asselin, JJ ;
Chan, JW ;
Hogg, RS ;
Harrigan, PR ;
O'Shaughnessy, MV ;
Montaner, JSG .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (12) :1972-1976
[10]   MITOCHONDRIAL MYOPATHY CAUSED BY LONG-TERM ZIDOVUDINE THERAPY [J].
DALAKAS, MC ;
ILLA, I ;
PEZESHKPOUR, GH ;
LAUKAITIS, JP ;
COHEN, B ;
GRIFFIN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (16) :1098-1105